Not approved (research only)Short bioregulator peptideRespiratory research
Bronchogen
Bronchogen is a short synthetic peptide from the bioregulator research tradition with limited published data.
What is Bronchogen?
Bronchogen is a short synthetic peptide from the bioregulator research tradition with limited published data. Bronchogen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Key takeaways
- Bronchogen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
- PubMed indexes 7 papers on Bronchogen (0 tagged as clinical trials) as of October 19, 2026.
- 7 vendors in our directory listed Bronchogen in their public catalog on October 19, 2026.
Structure
Regulatory & access status
Bronchogen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.
How much research exists on Bronchogen?
PubMed indexes 7 papers mentioning Bronchogen in the title or abstract, 0 of them from the last five years and 0 tagged as clinical trials (search run October 19, 2026; repeat the search).
Most relevant recent papers
- Effect of the peptide bronchogen (Ala-Asp-Glu-Leu) on DNA thermostability. — Bull Exp Biol Med, 2011
- Short Exogenous Peptides Regulate Expression of CLE, KNOX1, and GRF Family Genes in Nicotiana tabacum. — Biochemistry (Mosc), 2017
- Peptides tissue-specifically stimulate cell differentiation during their aging. — Bull Exp Biol Med, 2012
- Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung Pathology. — Bull Exp Biol Med, 2015
- Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. — Biochemistry (Mosc), 2011
- [ANTIINFLAMMATORY AND REGENERATIVE EFFECT OF PEPTIDE THERAPY IN THE MODEL OF OBSTRUCTIVE LUNG PATHOLOGY]. — Ross Fiziol Zh Im I M Sechenova, 2017
What the evidence does not show
- Paper counts measure research attention, not whether Bronchogen works or is safe.
- No clinical trial in humans is tagged in PubMed under this name.
- No FDA review of any "research use only" product's identity, purity, sterility or dose.
Research suppliers that list Bronchogen
7 vendors in our directory listed a product matching Bronchogen in their public catalog on October 19, 2026. Listed alphabetically; a listing is not an endorsement. Research use only.
Prices per mg, where we could verify them, are on our price comparison.
Bronchogen reconstitution math
Lab arithmetic only, not dosing guidance: use the peptide calculator to turn a vial size and diluent volume into a concentration.
Bronchogen FAQ
Is Bronchogen FDA-approved?
Bronchogen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Is Bronchogen safe?
There are no published human safety trials of Bronchogen that we could find. Products sold as "research use only" have no FDA review of purity, sterility or dose, and are not for human use.
How much research is there on Bronchogen?
PubMed indexes 7 papers on Bronchogen (0 tagged as clinical trials) as of October 19, 2026.
Who sells Bronchogen?
BioLongevity Labs, Bulk Peptide Supply, Core Peptides, Eros Peptides, Modern Aminos, Swiss Chems and 1 more listed it on their public catalogs when we checked; a listing is not an endorsement.
Related compounds
VIPLL-37TB-500ThymalinTRHMelanotan IThymogenThymosin alpha-1All immune supportAll bioregulators & other research compounds